NO306858B1 - Sulfonyl- eller sulfinylbenzoylguanidinderivater, farmasöytiske preparater som inneholder slike, samt anvendelse av dem til fremstilling av legemidler - Google Patents

Sulfonyl- eller sulfinylbenzoylguanidinderivater, farmasöytiske preparater som inneholder slike, samt anvendelse av dem til fremstilling av legemidler

Info

Publication number
NO306858B1
NO306858B1 NO963340A NO963340A NO306858B1 NO 306858 B1 NO306858 B1 NO 306858B1 NO 963340 A NO963340 A NO 963340A NO 963340 A NO963340 A NO 963340A NO 306858 B1 NO306858 B1 NO 306858B1
Authority
NO
Norway
Prior art keywords
halo
sulfinylbenzoylguanidine
pharmaceuticals
sulfonyl
derivatives
Prior art date
Application number
NO963340A
Other languages
English (en)
Other versions
NO963340D0 (no
NO963340L (no
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus-Otto Minck
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7769293&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO306858(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO963340D0 publication Critical patent/NO963340D0/no
Publication of NO963340L publication Critical patent/NO963340L/no
Publication of NO306858B1 publication Critical patent/NO306858B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Leads Or Probes (AREA)
NO963340A 1995-08-11 1996-08-09 Sulfonyl- eller sulfinylbenzoylguanidinderivater, farmasöytiske preparater som inneholder slike, samt anvendelse av dem til fremstilling av legemidler NO306858B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19529612A DE19529612A1 (de) 1995-08-11 1995-08-11 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Publications (3)

Publication Number Publication Date
NO963340D0 NO963340D0 (no) 1996-08-09
NO963340L NO963340L (no) 1997-02-12
NO306858B1 true NO306858B1 (no) 2000-01-03

Family

ID=7769293

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963340A NO306858B1 (no) 1995-08-11 1996-08-09 Sulfonyl- eller sulfinylbenzoylguanidinderivater, farmasöytiske preparater som inneholder slike, samt anvendelse av dem til fremstilling av legemidler

Country Status (25)

Country Link
US (1) US5744641A (no)
EP (1) EP0758644B1 (no)
JP (1) JP3901766B2 (no)
KR (1) KR100447111B1 (no)
CN (1) CN1071743C (no)
AR (1) AR004677A1 (no)
AT (1) ATE252075T1 (no)
AU (1) AU709800B2 (no)
BR (1) BR9603377B1 (no)
CA (1) CA2183050C (no)
CZ (1) CZ292974B6 (no)
DE (2) DE19529612A1 (no)
DK (1) DK0758644T3 (no)
ES (1) ES2206534T3 (no)
HU (1) HU226134B1 (no)
MX (1) MX9603300A (no)
NO (1) NO306858B1 (no)
PL (1) PL184320B1 (no)
PT (1) PT758644E (no)
RU (1) RU2159232C2 (no)
SI (1) SI0758644T1 (no)
SK (1) SK281661B6 (no)
TW (1) TW432039B (no)
UA (1) UA45965C2 (no)
ZA (1) ZA966773B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19833118C2 (de) * 1998-07-23 2000-07-27 Merck Patent Gmbh Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten
DE19903275A1 (de) * 1999-01-28 2000-08-03 Merck Patent Gmbh Lyophilisate mit verbesserter Rekonstituierbarkeit
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
KR100643561B1 (ko) * 2000-12-08 2006-11-10 엘지.필립스 엘시디 주식회사 액정표시장치용 어레이기판과 어레이기판의 제조방법
DE10305070A1 (de) * 2003-02-07 2004-08-26 Merck Patent Gmbh Verwendung von N-(4,5-Methansulfonyl-2-methyl-benzoyl)-guanidin
KR20060015580A (ko) * 2003-05-06 2006-02-17 메르크 파텐트 게엠베하 구아니디늄 염의 결정화 방법
DE102004045825A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid
AU2009243749B2 (en) 2008-05-09 2013-11-21 Merck Patent Gmbh Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
BRPI0918502A2 (pt) 2008-09-02 2015-12-01 Sanofi Aventis aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
FR2948028B1 (fr) 2009-07-17 2011-12-02 Merck Sante Sas Association d'un inhibiteur de l'echangeur sodium-proton et d'un derive amine de dihydro-1,3,5-triazine
JP7050005B2 (ja) 2016-02-08 2022-04-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｎ－（４，５－ビスメタンスルホニル－２－メチルベンゾイル）グアニジン塩酸塩およびｎ－（４，５－ビスメタンスルホニル－２－メチルベンゾイル）グアニジン塩の結晶変態
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
EP0604852A1 (de) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 2,4-Substituierte 5-(N-substituierte-Sulfamoyl)-Benzoylguanidine, als Antiarrythmika, Inhibitoren der Proliferationen von Zellen, und Inhibitoren des Natrium-Protonen-Antiporters
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
AU709800B2 (en) 1999-09-09
EP0758644B1 (de) 2003-10-15
SI0758644T1 (en) 2004-04-30
KR970010740A (ko) 1997-03-27
AR004677A1 (es) 1999-03-10
HUP9602196A2 (en) 1997-05-28
DE59610773D1 (de) 2003-11-20
BR9603377B1 (pt) 2009-01-13
HU226134B1 (en) 2008-05-28
SK281661B6 (sk) 2001-06-11
CZ292974B6 (cs) 2004-01-14
NO963340D0 (no) 1996-08-09
DE19529612A1 (de) 1997-02-13
PL315611A1 (en) 1997-02-17
ZA966773B (en) 1997-02-19
JPH0952876A (ja) 1997-02-25
HUP9602196A3 (en) 1998-07-28
NO963340L (no) 1997-02-12
ES2206534T3 (es) 2004-05-16
ATE252075T1 (de) 2003-11-15
CZ231296A3 (en) 1997-02-12
DK0758644T3 (da) 2003-12-22
PT758644E (pt) 2004-02-27
EP0758644A1 (de) 1997-02-19
CN1148590A (zh) 1997-04-30
RU2159232C2 (ru) 2000-11-20
CA2183050C (en) 2008-09-30
PL184320B1 (pl) 2002-10-31
AU6191796A (en) 1997-02-13
UA45965C2 (uk) 2002-05-15
SK103396A3 (en) 1997-03-05
CN1071743C (zh) 2001-09-26
KR100447111B1 (ko) 2004-12-08
US5744641A (en) 1998-04-28
HU9602196D0 (en) 1996-10-28
BR9603377A (pt) 1998-05-12
TW432039B (en) 2001-05-01
MX9603300A (es) 1997-03-29
CA2183050A1 (en) 1997-02-12
JP3901766B2 (ja) 2007-04-04

Similar Documents

Publication Publication Date Title
NO306858B1 (no) Sulfonyl- eller sulfinylbenzoylguanidinderivater, farmasöytiske preparater som inneholder slike, samt anvendelse av dem til fremstilling av legemidler
NO303685B1 (no) 4-amino-1-piperidylbenzoylguanidiner, farmasøytiske preparater som inneholder et slikt, og anvendelse av slike forbindelser til fremstilling av et legemiddel
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
CA2176373A1 (en) Farnesyl derivatives and pharmaceutical compositions containing them
DK0880508T3 (da) Quinazolinderivater som VEGF-inhibitorer
NO951543L (no) Polyenforbindelser, farmasöytiske og kosmetiske preparater inneholdende disse, og deres anvendelser
NO305125B1 (no) Farmas°ytiske forbindelser
GR3029894T3 (en) Heterocyclic substituted benzoylguanidine
BR9503854A (pt) Alquilbenzoilguanidinas compostos processo para a preparação de derivados de alquilbenzoilguanidina processo para produzir preparações farmacêuticas preparação farmacêutica e uso
NO306157B1 (no) Fluorholdige benzoylguanidiner, farmasöytiske preparater som inneholder minst én slik forbindelse, samt anvendelse av forbindelsene til fremstilling av et legemiddel
ATE172716T1 (de) Arylbenzoylguanidine
NO306991B1 (no) Alkenylbenzoylguanidinderivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
BR9504489A (pt) Derivados de benzoilguanidinas processo para sua preparaçao processo para a produçao de preparados farmacêuticos preparado farmacêutico e uso
FI963568A0 (fi) Peptidijohdannaisia
DK0694537T3 (da) Heterocyclyloxy-benzoylguanidinderivater, fremstilling deraf og anvendelse deraf som inhibitorer for den cellulære Na+/H+-antiporter
DK0686694T3 (da) Anvendelse af azoler som virucide midler i opløsninger af biologisk aktive proteiner
IL119054A0 (en) Substituted 4H-pyrans their preparation and pharmaceutical compositions containing them
FI921475A0 (fi) 1,4-dihydro-4-oxo-3-kinolinderivat som selektivt toxiska antibakteriella aemenn hos daeggdjur.
ES2133376T3 (es) Derivados de imidazol y su uso como agentes agroquimicos.
ATE86071T1 (de) Mikrobiozide mittel.
IT1247752B (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees